Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
2.080
+0.030 (1.46%)
At close: Dec 20, 2024, 4:00 PM
2.100
+0.020 (0.96%)
After-hours: Dec 20, 2024, 5:35 PM EST
Rockwell Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Rockwell Medical stock have an average target of 6.00, with a low estimate of 5.00 and a high estimate of 7.00. The average target predicts an increase of 188.46% from the current stock price of 2.08.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RMTI stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +236.54% | Nov 25, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +140.38% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +332.69% | Sep 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +332.69% | Sep 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +332.69% | Aug 12, 2024 |
Financial Forecast
Revenue This Year
102.49M
from 83.61M
Increased by 22.58%
Revenue Next Year
84.85M
from 102.49M
Decreased by -17.21%
EPS This Year
0.03
from -0.37
EPS Next Year
-0.06
from 0.03
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 106.6M | 92.0M | 95.1M |
| Avg | 102.5M | 84.9M | 92.4M |
| Low | 97.4M | 77.2M | 88.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 27.5% | -10.2% | 12.1% |
| Avg | 22.6% | -17.2% | 8.9% |
| Low | 16.5% | -24.7% | 4.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.03 | -0.03 | - |
| Avg | 0.03 | -0.06 | - |
| Low | 0.02 | -0.08 | - |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.